Biodiversity of secondary metabolites compounds isolated from phylum actinobacteria and its therapeutic applications

The current review aims to summarise the biodiversity and biosynthesis of novel secondary metabolites compounds, of the phylum Actinobacteria and the diverse range of secondary metabolites produced that vary depending on its ecological environments they inhabit. Actinobacteria creates a wide range o...

Full description

Bibliographic Details
Published in:Molecules
Main Author: Al-Shaibani M.M.; Mohamed R.M.S.R.; Sidik N.M.; Enshasy H.A.E.; Al-Gheethi A.; Noman E.; Al-Mekhlafi N.A.; Zin N.M.
Format: Review
Language:English
Published: MDPI AG 2021
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85111640457&doi=10.3390%2fmolecules26154504&partnerID=40&md5=f09d723459106e4e937c8c881759d103
id 2-s2.0-85111640457
spelling 2-s2.0-85111640457
Al-Shaibani M.M.; Mohamed R.M.S.R.; Sidik N.M.; Enshasy H.A.E.; Al-Gheethi A.; Noman E.; Al-Mekhlafi N.A.; Zin N.M.
Biodiversity of secondary metabolites compounds isolated from phylum actinobacteria and its therapeutic applications
2021
Molecules
26
15
10.3390/molecules26154504
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85111640457&doi=10.3390%2fmolecules26154504&partnerID=40&md5=f09d723459106e4e937c8c881759d103
The current review aims to summarise the biodiversity and biosynthesis of novel secondary metabolites compounds, of the phylum Actinobacteria and the diverse range of secondary metabolites produced that vary depending on its ecological environments they inhabit. Actinobacteria creates a wide range of bioactive substances that can be of great value to public health and the pharmaceutical industry. The literature analysis process for this review was conducted using the VOSviewer software tool to visualise the bibliometric networks of the most relevant databases from the Scopus database in the period between 2010 and 22 March 2021. Screening and exploring the available literature relating to the extreme environments and ecosystems that Actinobacteria inhabit aims to identify new strains of this major microorganism class, producing unique novel bioactive compounds. The knowledge gained from these studies is intended to encourage scientists in the natural product discovery field to identify and characterise novel strains containing various bioac-tive gene clusters with potential clinical applications. It is evident that Actinobacteria adapted to survive in extreme environments represent an important source of a wide range of bioactive com-pounds. Actinobacteria have a large number of secondary metabolite biosynthetic gene clusters. They can synthesise thousands of subordinate metabolites with different biological actions such as anti-bacterial, anti-parasitic, anti-fungal, anti-virus, anti-cancer and growth-promoting compounds. These are highly significant economically due to their potential applications in the food, nutrition and health industries and thus support our communities’ well-being. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
MDPI AG
14203049
English
Review
All Open Access; Gold Open Access
author Al-Shaibani M.M.; Mohamed R.M.S.R.; Sidik N.M.; Enshasy H.A.E.; Al-Gheethi A.; Noman E.; Al-Mekhlafi N.A.; Zin N.M.
spellingShingle Al-Shaibani M.M.; Mohamed R.M.S.R.; Sidik N.M.; Enshasy H.A.E.; Al-Gheethi A.; Noman E.; Al-Mekhlafi N.A.; Zin N.M.
Biodiversity of secondary metabolites compounds isolated from phylum actinobacteria and its therapeutic applications
author_facet Al-Shaibani M.M.; Mohamed R.M.S.R.; Sidik N.M.; Enshasy H.A.E.; Al-Gheethi A.; Noman E.; Al-Mekhlafi N.A.; Zin N.M.
author_sort Al-Shaibani M.M.; Mohamed R.M.S.R.; Sidik N.M.; Enshasy H.A.E.; Al-Gheethi A.; Noman E.; Al-Mekhlafi N.A.; Zin N.M.
title Biodiversity of secondary metabolites compounds isolated from phylum actinobacteria and its therapeutic applications
title_short Biodiversity of secondary metabolites compounds isolated from phylum actinobacteria and its therapeutic applications
title_full Biodiversity of secondary metabolites compounds isolated from phylum actinobacteria and its therapeutic applications
title_fullStr Biodiversity of secondary metabolites compounds isolated from phylum actinobacteria and its therapeutic applications
title_full_unstemmed Biodiversity of secondary metabolites compounds isolated from phylum actinobacteria and its therapeutic applications
title_sort Biodiversity of secondary metabolites compounds isolated from phylum actinobacteria and its therapeutic applications
publishDate 2021
container_title Molecules
container_volume 26
container_issue 15
doi_str_mv 10.3390/molecules26154504
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85111640457&doi=10.3390%2fmolecules26154504&partnerID=40&md5=f09d723459106e4e937c8c881759d103
description The current review aims to summarise the biodiversity and biosynthesis of novel secondary metabolites compounds, of the phylum Actinobacteria and the diverse range of secondary metabolites produced that vary depending on its ecological environments they inhabit. Actinobacteria creates a wide range of bioactive substances that can be of great value to public health and the pharmaceutical industry. The literature analysis process for this review was conducted using the VOSviewer software tool to visualise the bibliometric networks of the most relevant databases from the Scopus database in the period between 2010 and 22 March 2021. Screening and exploring the available literature relating to the extreme environments and ecosystems that Actinobacteria inhabit aims to identify new strains of this major microorganism class, producing unique novel bioactive compounds. The knowledge gained from these studies is intended to encourage scientists in the natural product discovery field to identify and characterise novel strains containing various bioac-tive gene clusters with potential clinical applications. It is evident that Actinobacteria adapted to survive in extreme environments represent an important source of a wide range of bioactive com-pounds. Actinobacteria have a large number of secondary metabolite biosynthetic gene clusters. They can synthesise thousands of subordinate metabolites with different biological actions such as anti-bacterial, anti-parasitic, anti-fungal, anti-virus, anti-cancer and growth-promoting compounds. These are highly significant economically due to their potential applications in the food, nutrition and health industries and thus support our communities’ well-being. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
publisher MDPI AG
issn 14203049
language English
format Review
accesstype All Open Access; Gold Open Access
record_format scopus
collection Scopus
_version_ 1809677893492539392